These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8377089)

  • 21. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE
    J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M
    J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M; Salame K; Raz I
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments.
    Touitou E; Alhaique F; Riccieri FM; Riccioni G; Santucci E
    Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
    Gai MN; Pezoa R; Corbeaux J; Arancibia A
    Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of in vitro release kinetics of flurbiprofen loaded ethylcellulose micropellets.
    Mallick S; Roy K; Chakraborty A; Saha S
    Acta Pol Pharm; 2002; 59(3):193-8. PubMed ID: 12230246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time and in situ drug release monitoring from nanoporous implants under dynamic flow conditions by reflectometric interference spectroscopy.
    Kumeria T; Gulati K; Santos A; Losic D
    ACS Appl Mater Interfaces; 2013 Jun; 5(12):5436-42. PubMed ID: 23731441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates.
    Karasulu E; Yeşim Karasulu H; Ertan G; Kirilmaz L; Güneri T
    Eur J Pharm Sci; 2003 Jun; 19(2-3):99-104. PubMed ID: 12791411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic principles in the design of immediate-release components in sustained-release formulations with zero-order release characteristics.
    Cheung WK; Silber BM; Yacobi A
    J Pharm Sci; 1991 Feb; 80(2):142-8. PubMed ID: 2051317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin.
    Takayama K; Nagai T
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):160-7. PubMed ID: 2720845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.